Speaker Profile
Ph.D., PHARMD, Associate Professor, U of Michigan
Biography
Academic researcher focusing in cancer biomarkers including pharmacogenetics, with particular interest in chemotherapy-induced peripheral neuropathy and clinical uptake of pre-treatment DPYD testing.
Session Abstract – PMWC 2025 Silicon Valley
Track 1 - February 7 9.00 A.M.-3.00 P.M.
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristin Wiisanen, Rosalind Franklin University
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jason Roos, ARPA-H
- Jennifer Wick, The Christ Hospital Health Network
- What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA
